BridgeMD
New treatment option for Ovarian Endometrioma
Official title Histological Assessment of Tissue Penetration Depth of Argon Beam Coagulation in Ovarian Endometriomas
ClinicalTrials.gov ID: NCT07711743
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the depth of tissue penetration of Argon Beam Coagulation (ABC) during laparoscopic surgery for ovarian endometriomas. Researchers want to determine how deeply ABC affects ovarian tissue and to generate data on the safety of this surgical technique.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Female patients aged 18-40 years.
- Indication for surgical treatment of ovarian endometrioma based on clinical symptoms and/or imaging findings.
- Diagnosis of ovarian endometrioma ≥3 cm confirmed by preoperative imaging (ultrasound and/or MRI).
- Planned laparoscopic cystectomy.
- Written informed consent.
You likely can't join if
- Expected lack of compliance or inability to understand the study procedures.
- Previous surgical procedures on the affected ovary.
- Recurrent ovarian endometrioma.
- Pregnancy or breastfeeding.
- Participation in another treatment clinical study that may influence study outcomes, such as anti-Müllerian hormone (AMH) levels or pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Canton of Bern, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Canton of Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.